LP28 : Efficacy of the oral sofosbuvir-based combinations in HCV genotype 4-mono-infected patients from the french observational cohort anrs CO22 hepather

H. Fontaine; C. Hezode; F. Zoulim; D. Samuel; M. Bourliere; G. Haour; C. Dorival-Mouly; V. Leroy; V. De Ledinghen; S. Lucier; D. Larrey; A. Tran; S. Metivier; Y. Benhamou; I. Hubert-Fouchard; F. Habersetzer; P. Marcellin; P. Mathurin; L. Alric; J.-P. Bronowicki; D. Guyader; V. Loustaud-Ratti; A. Minello; G. Riachi; I. Rosa; M. Simony; A. Diallo; F. Carrat; S. Pol

Journal Article

LP28 : Efficacy of the oral sofosbuvir-based combinations in HCV genotype 4-mono-infected patients from the french observational cohort anrs CO22 hepather

Fontaine H
Hezode C
Zoulim F
et al.

Journal of Hepatology (2015) 62 S278

DOI: 10.1016/s0168-8278(15)30182-3

N/ACitations

8Readers

Get full text

Cite

CITATION STYLE

APA

Fontaine, H., Hezode, C., Zoulim, F., Samuel, D., Bourliere, M., Haour, G., … Pol, S. (2015). LP28 : Efficacy of the oral sofosbuvir-based combinations in HCV genotype 4-mono-infected patients from the french observational cohort anrs CO22 hepather. Journal of Hepatology, 62, S278. https://doi.org/10.1016/s0168-8278(15)30182-3

LP28 : Efficacy of the oral sofosbuvir-based combinations in HCV genotype 4-mono-infected patients from the french observational cohort anrs CO22 hepather

Cite

Register to see more suggestions